According to the World Health Organisation (WHO) and the World Federation of Hemophilia around two thirds of the haemophilia patient population receive inadequate or no treatment at all.
Recent News
ProFactor Pharma Ltd. secures funding to develop a novel enhanced half-life recombinant human Factor VIII
ProFactor Pharma Ltd. (PFP), a UK biotech company, is pleased to announce it has been awarded a SMART: SCOTLAND grant from Scottish Enterprise. This grant has been awarded to perform a preclinical Proof-of-Concept study of a novel approach to significantly improve the...
World Hemophilia Day
The World Federation of Hemophilia (WFH) have set April 17, 2023 as World Hemophilia Day. The theme of the event this year is “Access for All: Prevention of bleeds as the global standard of care”. Building on last year’s theme, the call to action for the community in...